Results 171 to 180 of about 1,324,041 (317)
Abstract Background Huntington's disease (HD) is characterized by early, selective, progressive vulnerability of striatal medium spiny neurons (MSNs). Proenkephalin (PENK), a precursor of opioid peptides abundantly expressed in MSNs, is a promising biomarker of striatal integrity, but region‐specific associations and its potential for early‐stage ...
Mena Farag +14 more
wiley +1 more source
Commercial Health Plan Coverage of Selected Treatments for Opioid Use Disorders from 2003 to 2014 [PDF]
Sharon Reif +4 more
openalex +1 more source
The choroid plexus water density
Abstract Purpose To quantify normative ranges and circadian variability of the choroid plexus (ChP) water density in healthy adults. Methods Actigraphy assessments of circadian activity were performed for 5 days in healthy participants (n = 15; age = 28.5 ± 6.5 years) and subsequently participants underwent repeated, high spatial resolution proton ...
Abigail R. Dubois +8 more
wiley +1 more source
Evidence for differential opioid use disorder in schizophrenia in an addiction treatment population [PDF]
Joshua Chiappelli +3 more
openalex +1 more source
ABSTRACT Aims The objective of this study was to assess the duration and clinical correlates of positive response in interstitial cystitis/bladder pain syndrome patients undergoing therapeutic bladder hydrodistension (HOD) or HOD with electrofulguration (for those with Hunner lesions).
Dylan T. Wolff +5 more
wiley +1 more source
ABSTRACT The purpose of this study was to examine the association between hospital nurse staffing levels and 30‐ and 60‐day readmissions among patients with intellectual and/or developmental disabilities (IDD). This cross‐sectional correlational study utilized secondary data from 595 acute care, nonfederal hospitals in California, Florida, New Jersey ...
Lynne S. Moronski +2 more
wiley +1 more source
Antiobesity Medications for Older Adults—the New, the Good, the Bad, and the Unknown
ABSTRACT Objective Obesity affects 42% of older adults, with rates continuing to rise. This a complex condition influenced by non‐modifiable as well as modifiable risk factors. The disease can be treated through modifications to diet, physical activity, and behavior and more recently through antiobesity medications (AOMs) and surgery. Treatment must be
Anna Pendrey, Javier Sevilla‐Martir
wiley +1 more source
Management of Patients With Opioid Use Disorder (OUD). [PDF]
Martin-Orr N, Yun S.
europepmc +1 more source
Vermont Hub-and-Spoke Model of Care for Opioid Use Disorder: Development, Implementation, and Impact [PDF]
John R. Brooklyn, Stacey C. Sigmon
openalex +1 more source

